Investing
Exclusive-Icahn poised to win at least one seat on Illumina’s board -sources
© Reuters. FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake
By Svea Herbst-Bayliss and Greg Roumeliotis
NEW YORK (Reuters) -Activist investor Carl Icahn is set to win enough Illumina Inc (NASDAQ:) shareholder support to install at least one of his three nominees to the gene sequencing machine maker’s board, two people familiar with the matter said on Wednesday.
A preliminary vote tally shows that Icahn nominee Andrew Teno has won enough shareholder support to get on Illumina’s board, the sources said.
The sources added that the tally has not been finalised and Illumina shareholders can change their votes until the company’s annual shareholder meeting starts on Thursday.
The sources asked not to be identified because the matter is confidential. Icahn and Illumina spokespeople did not immediately respond to requests for comment.
Icahn’s challenge against Illumina, whose market value of $33 billion makes it this year’s biggest board fight, offers the 87-year-old corporate raider a chance to reassert his investment acumen.
This month, he faced his own investor challenge after short seller Hindenburg Research issued a report saying his investment firm Icahn Enterprises LP artificially inflated its dividend yield and the value of its assets.
Icahn, who owns 1.4% of Illumina, put forward three director candidates, a move that could result in the ouster of Chief Executive Officer Francis deSouza and Chairman John Thompson from Illumina’s nine-member board.
The investor has accused Illumina’s board of poor oversight, especially with regards to the company’s $7.1 billion acquisition of cancer test maker Grail.
Illumina completed the deal despite opposition from U.S. and European antitrust regulators, who are now trying to force it to unwind it. Icahn has blamed the Grail deal for Illumina losing $50 billion in market value.
Earlier this month, proxy advisory firm Institutional Shareholder Services recommended Illumina shareholders back Teno, arguing he would be an adequate replacement for Thompson.
Two days earlier, proxy adviser Glass Lewis said Illumina shareholders should vote for two of Carl Icahn’s nominees to replace deSouza and Thompson.
Read the full article here
What to Do If TikTok is Banned — How to Protect Your Brand
10 Roles That Are Surprisingly Well-Suited for Outsourcing
How AI Can Make Us Better Leaders
How Pets Can Promote Better Health and Well-Being in the Workplace
Biden cancels more student loans with one week left to his term
10 Critical Questions to Ask Your Financial Advisor Now
10 Ways to Make Money As a Graphic Designer
If you are 60 years old, new 401(k) rules could save you money
Could Easier Cancellations Build Customer Loyalty?
Airbus keeps top spot with 766 jet deliveries in 2024 By Reuters
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Make Money7 days ago10 Critical Questions to Ask Your Financial Advisor Now
-
Make Money6 days ago10 Ways to Make Money As a Graphic Designer
-
Personal Finance5 days agoIf you are 60 years old, new 401(k) rules could save you money
-
Investing6 days agoCould Easier Cancellations Build Customer Loyalty?
-
Investing7 days agoAirbus keeps top spot with 766 jet deliveries in 2024 By Reuters
-
Investing4 days agoBank regulator gives BlackRock new deadline on bank stakes, Bloomberg reports By Reuters
-
Side Hustles6 days agoTrump’s 2025 Inaugural Committee Raises Record $170 Million
-
Passive Income7 days agoHow to Build a Solid Go-to-Market Strategy for 2025